GO:0046789 host cell surface receptor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046789 host cell surface receptor binding is a molecular function defined as binding to a receptor on the host cell surface [QuickGO].
• It is the first committed step for many pathogens, including influenza A virus hemagglutinin binding to sialic acid receptors, adeno-associated virus capsid binding to AAVR, and gammaretrovirus envelope binding to cell surface receptors.
• The interaction is not passive: receptor binding can trigger conformational changes, endocytosis, and downstream signaling, as shown for anthrax toxin and hIFNγ–hIFNGR1.
• Host range and tissue tropism are often determined by receptor-binding specificity, exemplified by cattle-infecting H5N1 hemagglutinin and influenza A virus receptor preference.
• AAV2 capsid–receptor recognition can be modulated by allostery-driven mutations, making it a tractable target for vector engineering.
• Studying this function requires integrated structural, biochemical, and CRISPR-based approaches to distinguish binding from downstream entry and signaling [2,4].
Description
GO:0046789 host cell surface receptor binding is a molecular function that describes the binding of a ligand, toxin, viral protein, or other molecule to a receptor located on the surface of a host cell [QuickGO]. This term captures the initial recognition event that often determines whether a pathogen, cytokine, or therapeutic agent can engage a specific cell type. Because the host cell surface is the first interface between an external agent and the cell interior, receptor binding is a central node in infection, immunity, and drug action [6,8]. Researchers study this function to understand tropism, to identify therapeutic targets, and to engineer vectors or inhibitors with altered specificity [1,4]. The definition is intentionally broad: it includes viral attachment proteins, bacterial adhesins, and host-derived ligands that bind surface receptors [5,7]. In practice, host cell surface receptor binding is measured by direct binding assays, structural biology, and functional entry or signaling readouts [2,3].
host cell surface receptor binding At A Glance
| GO ID | GO:0046789 |
|---|---|
| GO term | host cell surface receptor binding |
| Ontology | molecular_function |
| Synonym | cell surface antigen activity, host-interacting; cell surface receptor ligand |
| Definition | Binding to a receptor on the host cell surface. |
| Major function | Initial recognition of host cell surface receptors by viral, bacterial, or host ligands. |
| Representative ligands | Influenza hemagglutinin, AAV capsid, gammaretroviral envelope, anthrax protective antigen, interferon gamma. |
| Representative receptors | Sialic acid, AAVR, Pit1/Pit2, ANTXR1/ANTXR2, IFNGR1. |
| Disease relevance | Viral infection, toxin-mediated disease, cytokine signaling disorders, cancer. |
What Is GO:0046789?
In our own words, GO:0046789 host cell surface receptor binding is the molecular activity of a protein or other molecule binding to a receptor that is displayed on the outer surface of a host cell. The term is a molecular_function in the Gene Ontology and is supported by the QuickGO definition: Binding to a receptor on the host cell surface. It is synonymous with cell surface antigen activity, host-interacting, and cell surface receptor ligand. This function is upstream of processes such as viral entry, toxin internalization, and cytokine signaling, and it is often the determinant of host range and tissue tropism [1,6].
Why Is host cell surface receptor binding Important in Cell Biology?
Host cell surface receptor binding is important because it is the first committed step in many infectious and signaling processes. For influenza A virus, hemagglutinin binding to sialic acid receptors determines host specificity and tissue tropism, and mutations in the receptor-binding site can shift host range [1,6]. For adeno-associated virus, the discovery of AAVR as an essential receptor provided a mechanistic basis for vector tropism and gene therapy design. For bacterial toxins such as anthrax toxin, receptor binding is required for delivery of toxic payloads into cells. For host cytokines such as interferon gamma, binding to IFNGR1 is a prerequisite for signaling, and heparan sulfate can facilitate this interaction. Because receptor binding is often rate-limiting and specific, it is a prime target for antiviral drugs, vaccines, and engineered vectors [4,8].
• Determines host range and tissue tropism for viruses such as influenza A virus and gammaretroviruses [1,6,8].
• Provides the first step for adeno-associated virus infection and gene therapy vector entry [2,4].
• Enables bacterial toxin internalization, as shown for anthrax toxin.
• Facilitates cytokine signaling, exemplified by hIFNγ binding to hIFNGR1.
• Is a target for antiviral and antitoxin therapeutics [5,6].
• Can be engineered by mutations that alter receptor specificity, as modeled for AAV2.
• Is relevant to cancer biology when surface receptors are overexpressed or mutated.
• Underpins vaccine design by defining neutralizing epitopes at receptor interfaces.
• Is studied with structural biology, binding assays, and CRISPR screens [2,4].
• Links pathogen biology to host genetics through receptor polymorphisms.
Molecular Mechanism of host cell surface receptor binding
Initial recognition and attachment
In simple terms: The ligand first sticks to a receptor on the outside of the host cell.
The first stage of host cell surface receptor binding is the reversible attachment of a ligand to a receptor displayed on the host cell surface. For influenza A virus, the hemagglutinin protein binds sialic acid-containing glycans, and the specificity of this interaction influences host-specific infection. For adeno-associated virus, the capsid engages AAVR as an essential receptor, and this interaction is required for infection. For gammaretroviruses, envelope proteins bind specific cell surface receptors to initiate entry. This step is often low-affinity and can be facilitated by accessory molecules such as heparan sulfate for hIFNγ–hIFNGR1 binding.
Conformational changes and co-receptor engagement
In simple terms: After binding, the ligand or receptor changes shape to allow the next step.
Following initial attachment, receptor binding can induce conformational changes in the ligand that expose co-receptor binding sites or membrane insertion domains. Anthrax toxin protective antigen binds to ANTXR1 or ANTXR2 and then undergoes cleavage and oligomerization to form a pore that translocates lethal factor and edema factor. In influenza A virus, receptor binding and low pH trigger hemagglutinin conformational changes that drive membrane fusion. For AAV2, allostery-driven mutations in the capsid can modulate receptor recognition, indicating that conformational plasticity is part of the binding mechanism.
Signaling and downstream consequences
In simple terms: Binding can send a signal into the cell or start uptake.
Host cell surface receptor binding is not always merely an attachment event; it can activate signaling or endocytic pathways. Interferon gamma binding to IFNGR1 leads to receptor dimerization and downstream JAK-STAT signaling, and heparan sulfate facilitates this interaction. For phagocyte-bacteria interactions, receptor binding can trigger phagocytosis and inflammatory responses. For gammaretroviruses, receptor binding leads to membrane fusion and delivery of the viral genome. These downstream consequences are often used as functional readouts of receptor binding in experiments [2,5].
Specificity and host range
In simple terms: Small differences in binding can decide which species or cells a pathogen can infect.
The specificity of host cell surface receptor binding is a major determinant of host range and tissue tropism. Cattle-infecting H5N1 avian influenza virus hemagglutinin shows receptor-binding properties that help explain its tropism. Influenza A virus hemagglutinin receptor binding and pH stability together affect host-specific infection. AAV2 capsid–receptor recognition can be modulated by mutations, which has implications for vector targeting. Gammaretrovirus cell surface receptors define the host range of different retroviral strains.
Regulation and modulation of binding
In simple terms: The cell can change how well a receptor binds by adding sugars or changing receptor levels.
Host cell surface receptor binding can be regulated by post-translational modifications of the receptor, by accessory molecules, and by receptor abundance. Heparan sulfate facilitates binding of hIFNγ to hIFNGR1, illustrating how a glycosaminoglycan can modulate a receptor–ligand interaction. Receptor expression levels and alternative splicing can also affect binding, as seen for gammaretrovirus receptors. In the case of AAV, allosteric mutations in the capsid can alter receptor recognition without abolishing capsid assembly. These regulatory layers provide opportunities for therapeutic intervention [2,5].
Key Genes Involved in GO:0046789 host cell surface receptor binding
The following genes and proteins are representative ligands or receptors that carry out or are directly involved in host cell surface receptor binding, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HA (influenza A virus hemagglutinin) | Binds sialic acid receptors on host cells | Determines host range and tropism; target for antivirals and vaccines [1,6] |
| AAVR (KIAA0319L) | Essential receptor for adeno-associated virus infection | Required for AAV entry; key for gene therapy vector design |
| AAV2 capsid (VP1/VP2/VP3) | Binds AAVR and other surface receptors | Capsid mutations can modulate receptor recognition |
| IFNGR1 | Cell surface receptor for interferon gamma | Binding is facilitated by heparan sulfate; relevant to immune signaling |
| IFNG | Ligand for IFNGR1 | Cytokine that binds host cell surface receptor to trigger signaling |
| ANTXR1 (TEM8) | Receptor for anthrax protective antigen | Mediates toxin entry; target for antitoxin strategies |
| ANTXR2 (CMG2) | Receptor for anthrax protective antigen | Alternative receptor for anthrax toxin entry |
| Pit1 (SLC20A1) | Gammaretrovirus receptor | Determines host range of gammaretroviruses |
| Pit2 (SLC20A2) | Gammaretrovirus receptor | Alternative receptor for gammaretrovirus entry |
| Env (gammaretroviral envelope) | Binds cell surface receptors | Mediates entry and tropism |
| PA (anthrax protective antigen) | Binds ANTXR1/ANTXR2 | Forms pore for toxin delivery |
| LF (lethal factor) | Binds PA complex | Toxin effector delivered after receptor binding |
| EF (edema factor) | Binds PA complex | Toxin effector delivered after receptor binding |
| Sialic acid (glycan) | Ligand for influenza hemagglutinin | Receptor determinant for influenza A virus |
| Heparan sulfate | Facilitates hIFNγ–hIFNGR1 binding | Modulates cytokine-receptor interaction |
| Phagocyte receptors | Bind bacteria for phagocytosis | Host defense mechanism |
| Bacterial adhesins | Bind host cell surface receptors | Mediate bacterial attachment and colonization |
How Is host cell surface receptor binding Regulated?
Host cell surface receptor binding is regulated at multiple levels. Receptor abundance and post-translational modifications, such as glycosylation, can alter binding affinity; heparan sulfate facilitates hIFNγ binding to hIFNGR1. Accessory molecules and co-receptors can stabilize or modulate the interaction, as seen for anthrax toxin receptors. In viruses, receptor-binding specificity can be controlled by mutations in the ligand, exemplified by influenza hemagglutinin adaptations [1,6] and AAV capsid allostery. Host genetic variation in receptor genes can also affect susceptibility, as described for gammaretrovirus receptors.
host cell surface receptor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HA (influenza A virus) | Influenza, host range, tissue tropism | Point-mutation knock-in of HA receptor-binding site in viral reverse genetics [1,6] |
| AAVR (KIAA0319L) | AAV infection, gene therapy vector entry | Knockout cell lines to test AAV transduction |
| IFNGR1 | Immune signaling disorders | Knockout and knock-in of IFNGR1 to study hIFNγ binding |
| ANTXR1/ANTXR2 | Anthrax toxin entry | Knockout cells to block toxin binding |
| Pit1/Pit2 | Gammaretrovirus infection, vector tropism | Overexpression and knockout to test retroviral entry |
Viral infections and host range
Host cell surface receptor binding is central to viral infection. Influenza A virus hemagglutinin binding to sialic acid receptors determines host-specific infection, and cattle-infecting H5N1 hemagglutinin receptor-binding properties help explain tissue tropism [1,6]. Adeno-associated virus requires AAVR for infection, and capsid mutations can alter receptor recognition [2,4]. Gammaretrovirus envelope binding to Pit1/Pit2 receptors defines host range and entry. These interactions are targets for antiviral drugs and vaccines.
Bacterial toxins and infectious disease
Anthrax toxin protective antigen binds ANTXR1 or ANTXR2 on host cells, leading to toxin internalization and disease. Phagocyte-bacteria interactions involve receptor binding that can trigger phagocytosis or immune evasion. Understanding these binding events informs antitoxin and antibacterial strategies [5,7].
Cytokine signaling and immune disorders
Interferon gamma binds IFNGR1 on the host cell surface, and heparan sulfate facilitates this interaction. Dysregulation of this binding can affect immune responses and inflammatory diseases. Receptor binding is therefore relevant to cytokine-based therapies and immune modulation.
Cancer and gene therapy
Cell surface receptors for gammaretroviruses are expressed in various tissues and can influence retroviral vector tropism in gene therapy and cancer models. AAV vectors rely on receptor binding for delivery, and engineering capsid-receptor interactions can improve targeting [2,4]. These applications link host cell surface receptor binding to therapeutic development [2,4,8].
From host cell surface receptor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate receptor mediate viral entry? | CRISPR knockout of receptor gene followed by infection assay |
| Does a point mutation in the ligand alter receptor specificity? | Point-mutation knock-in of ligand gene [1,4] |
| Can a tagged receptor be used to track binding? | Knock-in of epitope tag at endogenous locus |
| Does overexpression of a receptor increase binding? | Overexpression cell model |
| Which host genes regulate receptor binding? | CRISPR library screening [2,4] |
| Can binding be blocked by a therapeutic? | Competition binding assay in wild-type and mutant cells [5,6] |
How to Study the host cell surface receptor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance | Binding affinity and kinetics | Measure ligand–receptor interaction |
| Flow cytometry | Cell surface binding | Detect receptor expression and ligand binding |
| Cryo-EM | High-resolution structure | Visualize receptor–ligand interface [1,2] |
| Infection assay | Viral entry | Test receptor requirement [2,8] |
| Toxin cytotoxicity assay | Toxin delivery | Assess anthrax toxin receptor binding |
| CRISPR knockout screen | Host genes required for binding/entry | Identify novel receptors [2,4] |
| Phospho-STAT signaling assay | Cytokine receptor activation | Measure IFNγ signaling after binding |
| Competition binding assay | Specificity of binding | Test inhibitors or receptor blockers |
Binding assays
Direct binding assays, such as ELISA, surface plasmon resonance, and flow cytometry, measure the interaction between a ligand and host cell surface receptor. These methods are used to quantify affinity and specificity, as shown for hIFNγ–hIFNGR1 and influenza hemagglutinin–sialic acid.
Structural biology
X-ray crystallography and cryo-electron microscopy reveal atomic details of receptor–ligand interfaces. Structures of influenza hemagglutinin with receptor analogs and AAV capsid–AAVR complexes have informed understanding of binding specificity [1,2,4].
Functional entry and signaling assays
Infection assays, toxin cytotoxicity assays, and cytokine signaling readouts (e.g., STAT phosphorylation) measure the downstream consequences of receptor binding. These are used to confirm that binding leads to functional entry or signaling [2,5,3].
CRISPR screening and genomics
Genome-wide CRISPR knockout or activation screens can identify host genes required for receptor binding or entry. Such screens have been used to discover AAVR and to map host factors for viral infection [2,4].
How CRISPR Can Be Used to Study GO:0046789 host cell surface receptor binding
Knockout
CRISPR knockout of candidate receptor genes is used to test whether a specific host cell surface receptor is required for binding and entry. For example, knockout of AAVR abolishes AAV infection, confirming its essential receptor role. Knockout of ANTXR1/ANTXR2 reduces anthrax toxin binding and cytotoxicity.
Point Mutation
Point mutations can be introduced into ligand or receptor genes to map residues that determine binding specificity. For influenza hemagglutinin, point mutations in the receptor-binding site can alter sialic acid preference and host range [1,6]. For AAV2 capsid, allostery-driven mutations modulate receptor recognition.
Knock-in
Knock-in of epitope tags or reporter genes at endogenous receptor loci allows tracking of receptor expression and binding in live cells. This approach can be used for IFNGR1 or AAVR to study trafficking and interaction dynamics [2,3].
Overexpression
Overexpression of a receptor or ligand can enhance binding and downstream signaling, providing a gain-of-function system. Overexpression of gammaretrovirus receptors Pit1/Pit2 increases viral entry, confirming receptor function. Overexpression of IFNGR1 can amplify hIFNγ signaling.
How EDITGENE Supports host cell surface receptor binding Research
Researchers studying host cell surface receptor binding-related genes often need to determine whether a candidate gene is causally involved in binding, entry, or downstream signaling. EDITGENE provides CRISPR-based cell model services to enable precise genetic perturbations and functional validation.
Contact EDITGENE today to design your custom CRISPR model for host cell surface receptor binding research.
Frequently Asked Questions About host cell surface receptor binding
What is GO:0046789 host cell surface receptor binding?
GO:0046789 is a Gene Ontology molecular function defined as binding to a receptor on the host cell surface. It includes viral attachment proteins, bacterial adhesins, and host ligands that engage surface receptors [QuickGO].
What genes are involved in host cell surface receptor binding?
Representative genes include influenza HA, AAVR (KIAA0319L), AAV2 capsid, IFNGR1, IFNG, ANTXR1, ANTXR2, Pit1 (SLC20A1), Pit2 (SLC20A2), and gammaretroviral Env [1,2,3,5,8].
How does influenza hemagglutinin bind host cells?
Influenza hemagglutinin binds sialic acid-containing receptors on the host cell surface, and this interaction determines host-specific infection and tissue tropism [1,6].
What is the receptor for adeno-associated virus?
AAVR (KIAA0319L) is an essential receptor for adeno-associated virus infection, and AAV capsid binding to AAVR is required for entry.
How is host cell surface receptor binding studied?
It is studied using binding assays, structural biology, functional entry assays, and CRISPR screens to identify host factors [2,3,4].
Why is host cell surface receptor binding important for disease?
It is the first step in viral infection, toxin entry, and cytokine signaling, making it a target for antiviral, antitoxin, and immune therapies [5,6].
Can CRISPR be used to study host cell surface receptor binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of receptor–ligand interactions [2,4,8].
What is the role of heparan sulfate in receptor binding?
Heparan sulfate facilitates binding of hIFNγ to its cell surface receptor hIFNGR1, illustrating how accessory molecules modulate binding.
Which toxins bind host cell surface receptors?
Anthrax toxin protective antigen binds ANTXR1 and ANTXR2 on host cells to initiate toxin entry.
What are synonyms for GO:0046789?
Synonyms include cell surface antigen activity, host-interacting, and cell surface receptor ligand [QuickGO].
Conclusion
GO:0046789 host cell surface receptor binding is a fundamental molecular function that governs the first contact between pathogens, toxins, or host ligands and the cell surface. Its specificity determines host range, tissue tropism, and downstream signaling, with direct implications for infectious disease, immunity, and gene therapy [1,2,5,6]. Continued research using structural biology, functional assays, and CRISPR-based models will clarify how receptor binding can be targeted or engineered for therapeutic benefit [3,4,8].
References
- 1. Song H et al.. 2025. Receptor binding, structure, and tissue tropism of cattle-infecting H5N1 avian influenza virus hemagglutinin.. Cell 188(4):919-929.e9 PMID: 39848246
- 2. Pillay S et al.. 2016. An essential receptor for adeno-associated virus infection.. Nature 530(7588):108-12 PMID: 26814968
- 3. Miladinova E et al.. 2022. Heparan Sulfate Facilitates Binding of hIFNγ to Its Cell-Surface Receptor hIFNGR1.. Int J Mol Sci 23(16) PMID: 36012678
- 4. Naskar R et al.. 2025. Understanding the host cell surface receptor recognition by adeno associated virus 2 capsid protein and its modulation through allostery-driven mutations: An integrative modelling and simulation approach.. Int J Biol Macromol 332(Pt 2):148553 PMID: 41151708
- 5. Collier RJ et al.. 2003. Anthrax toxin.. Annu Rev Cell Dev Biol 19:45-70 PMID: 14570563
- 6. Mair CM et al.. 2014. Receptor binding and pH stability - how influenza A virus hemagglutinin affects host-specific virus infection.. Biochim Biophys Acta 1838(4):1153-68 PMID: 24161712
- 7. Keisari Y et al.. 1997. Phagocyte-bacteria interactions.. Adv Dent Res 11(1):43-9 PMID: 9524441
- 8. Tailor CS et al.. 2003. Cell surface receptors for gammaretroviruses.. Curr Top Microbiol Immunol 281:29-106 PMID: 12932075
